학술논문
Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapsed Multiple Myeloma.
Document Type
journal article
Source
Annals of Pharmacotherapy; Jun2020, Vol. 54 Issue 6, p577-582, 6p
Subject
Language
ISSN
10600280
Abstract
Copyright of Annals of Pharmacotherapy is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)